Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to specify the serotype distribution of Streptococcus pneumoniae that causes invasive diseases at children and adults in Turkey.


Clinical Trial Description

Non-interventional observational study Descriptive analysis will be conducted. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01810861
Study type Observational
Source Pfizer
Contact
Status Completed
Phase
Start date January 4, 2013
Completion date July 31, 2019

See also
  Status Clinical Trial Phase
Completed NCT02126384 - Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response N/A